Schedule 13G ownership disclosure
ESSA PHARMA INC
Security class unavailable · CUSIP: 29668H708
Event date: 2020-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,675,000
- Percent of class
- 6.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-20-000062
- Form type
- SC 13G
- Filer
- ESSA Pharma Inc.
- CIK
- CIK 1633932
- Filed
- Aug 06, 2020
- Reporting period
- Jul 31, 2020
- Description
- Schedule 13G beneficial ownership